Jul 202011

Macau, Hong Kong Order GSK To Recall Augmentin Due To Plasticizer ContaminationHong Kong & Macau have ordered pharmaceutical major GlaxoSmithKline (GSK) to recall the antibiotic Augmentin used for treating infections because it contained detectable levels of chemical additives.

According to the Hong Kong health department, tests revealed GSK’s Augmentin antibiotic tablet (375mg) contained several plasticisers, including diisodecyl phthalate (DIDP) & di(2-ethylhexyl) phthalate (DEHP), raising “quality concerns”.

The information was supplied toMacau’s Health Bureau which also ordered the British firm to recall the antibiotic.

Augmentin 375mg tablet is an antibiotic for treating bacterial infections.

Health authorities say the amount of chemicals found in Augmentin tablets was “considered unlikely to cause acute harmful effects if the tablets were taken according to the recommended dosage”.

Further tests have been carried out but the sources of the plasticisers are still to be determined. As GSK could not provide satisfactory explanation on sources of the plasticisers, the quality of the product is in question.

Residents can contact the Department of Pharmaceutical Affairs of the Health Bureau (85983523/66833329) to get more information.

GlaxoSmithKline said it had launched an “urgent and thorough investigation” to determine the source of the additives.

Macau, Hong Kong Order GSK To Recall Augmentin Due To Plasticizer Contamination was last modified: May 13th, 2013 by Shil


Shil is a freelance writer, professional blogger and a social media enthusiast.